Global Radiopharmaceuticals Market Growth 2021-2026


Jul, 2021 | Report ID: 205678 | 112 | Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Radiopharmaceuticals will have significant change from previous year. By the most conservative estimates of global Radiopharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 6123.9 million in 2020. Over the next five years the Radiopharmaceuticals market will register a 8.3% CAGR in terms of revenue, the global market size will reach US$ 8424.2 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Diagnostic Radioisotopes

Therapeutic Radioisotopes

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Oncology

Cardiology

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Radiopharmaceuticals Consumption 2016-2026

2.1.2 Radiopharmaceuticals Consumption CAGR by Region

2.2 Radiopharmaceuticals Segment by Type

2.2.1 Diagnostic Radioisotopes

2.2.2 Therapeutic Radioisotopes

2.3 Radiopharmaceuticals Sales by Type

2.3.1 Global Radiopharmaceuticals Sales Market Share by Type (2016-2021)

2.3.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2016-2021)

2.3.3 Global Radiopharmaceuticals Sale Price by Type (2016-2021)

2.4 Radiopharmaceuticals Segment by Application

2.4.1 Oncology

2.4.2 Cardiology

2.4.3 Other

2.5 Radiopharmaceuticals Sales by Application

2.5.1 Global Radiopharmaceuticals Sale Market Share by Application (2016-2021)

2.5.2 Global Radiopharmaceuticals Revenue and Market Share by Application (2016-2021)

2.5.3 Global Radiopharmaceuticals Sale Price by Application (2016-2021)

3 Global Radiopharmaceuticals by Company

3.1 Global Radiopharmaceuticals Sales Market Share by Company

3.1.1 Global Radiopharmaceuticals Sales by Company (2019-2021)

3.1.2 Global Radiopharmaceuticals Sales Market Share by Company (2019-2021)

3.2 Global Radiopharmaceuticals Revenue Market Share by Company

3.2.1 Global Radiopharmaceuticals Revenue by Company (2019-2021)

3.2.2 Global Radiopharmaceuticals Revenue Market Share by Company (2019-2021)

3.3 Global Radiopharmaceuticals Sale Price by Company

3.4 Global Manufacturers Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Radiopharmaceuticals Product Location Distribution

3.4.2 Players Radiopharmaceuticals Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Radiopharmaceuticals by Region

4.1 Global Radiopharmaceuticals by Region

4.1.1 Global Radiopharmaceuticals Sales by Region

4.1.2 Global Radiopharmaceuticals Revenue by Region

4.2 Americas Radiopharmaceuticals Sales Growth

4.3 APAC Radiopharmaceuticals Sales Growth

4.4 Europe Radiopharmaceuticals Sales Growth

4.5 Middle East & Africa Radiopharmaceuticals Sales Growth

5 Americas

5.1 Americas Radiopharmaceuticals Sales by Country

5.1.1 Americas Radiopharmaceuticals Sales by Country (2016-2021)

5.1.2 Americas Radiopharmaceuticals Revenue by Country (2016-2021)

5.2 Americas Radiopharmaceuticals Sales by Type

5.3 Americas Radiopharmaceuticals Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Radiopharmaceuticals Sales by Region

6.1.1 APAC Radiopharmaceuticals Sales by Region (2016-2021)

6.1.2 APAC Radiopharmaceuticals Revenue by Region (2016-2021)

6.2 APAC Radiopharmaceuticals Sales by Type

6.3 APAC Radiopharmaceuticals Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Radiopharmaceuticals by Country

7.1.1 Europe Radiopharmaceuticals Sales by Country (2016-2021)

7.1.2 Europe Radiopharmaceuticals Revenue by Country (2016-2021)

7.2 Europe Radiopharmaceuticals Sales by Type

7.3 Europe Radiopharmaceuticals Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Radiopharmaceuticals by Country

8.1.1 Middle East & Africa Radiopharmaceuticals Sales by Country (2016-2021)

8.1.2 Middle East & Africa Radiopharmaceuticals Revenue by Country (2016-2021)

8.2 Middle East & Africa Radiopharmaceuticals Sales by Type

8.3 Middle East & Africa Radiopharmaceuticals Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Radiopharmaceuticals Distributors

10.3 Radiopharmaceuticals Customer

11 Global Radiopharmaceuticals Market Forecast

11.1 Global Radiopharmaceuticals Forecast by Region

11.1.1 Global Radiopharmaceuticals Forecast by Regions (2021-2026)

11.2.2 Global Radiopharmaceuticals Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Radiopharmaceuticals Forecast by Type

11.7 Global Radiopharmaceuticals Forecast by Application

12 Key Players Analysis

12.1 Bracco Imaging

12.1.1 Bracco Imaging Company Information

12.1.2 Bracco Imaging Radiopharmaceuticals Product Offered

12.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Bracco Imaging Main Business Overview

12.1.5 Bracco Imaging Latest Developments

12.2 Bayer

12.2.1 Bayer Company Information

12.2.2 Bayer Radiopharmaceuticals Product Offered

12.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Bayer Main Business Overview

12.2.5 Bayer Latest Developments

12.3 Mallinckrodt

12.3.1 Mallinckrodt Company Information

12.3.2 Mallinckrodt Radiopharmaceuticals Product Offered

12.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Mallinckrodt Main Business Overview

12.3.5 Mallinckrodt Latest Developments

12.4 Nordion

12.4.1 Nordion Company Information

12.4.2 Nordion Radiopharmaceuticals Product Offered

12.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Nordion Main Business Overview

12.4.5 Nordion Latest Developments

12.5 Triad Isotopes

12.5.1 Triad Isotopes Company Information

12.5.2 Triad Isotopes Radiopharmaceuticals Product Offered

12.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Triad Isotopes Main Business Overview

12.5.5 Triad Isotopes Latest Developments

12.6 Lantheus

12.6.1 Lantheus Company Information

12.6.2 Lantheus Radiopharmaceuticals Product Offered

12.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Lantheus Main Business Overview

12.6.5 Lantheus Latest Developments

12.7 IBA Group

12.7.1 IBA Group Company Information

12.7.2 IBA Group Radiopharmaceuticals Product Offered

12.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 IBA Group Main Business Overview

12.7.5 IBA Group Latest Developments

12.8 GE Healthcare

12.8.1 GE Healthcare Company Information

12.8.2 GE Healthcare Radiopharmaceuticals Product Offered

12.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 GE Healthcare Main Business Overview

12.8.5 GE Healthcare Latest Developments

12.9 China Isotope & Radiation

12.9.1 China Isotope & Radiation Company Information

12.9.2 China Isotope & Radiation Radiopharmaceuticals Product Offered

12.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 China Isotope & Radiation Main Business Overview

12.9.5 China Isotope & Radiation Latest Developments

12.10 Jubilant Pharma

12.10.1 Jubilant Pharma Company Information

12.10.2 Jubilant Pharma Radiopharmaceuticals Product Offered

12.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Jubilant Pharma Main Business Overview

12.10.5 Jubilant Pharma Latest Developments

12.11 Eli Lilly

12.11.1 Eli Lilly Company Information

12.11.2 Eli Lilly Radiopharmaceuticals Product Offered

12.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Eli Lilly Main Business Overview

12.11.5 Eli Lilly Latest Developments

12.12 Advanced Accelerator Applications

12.12.1 Advanced Accelerator Applications Company Information

12.12.2 Advanced Accelerator Applications Radiopharmaceuticals Product Offered

12.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Advanced Accelerator Applications Main Business Overview

12.12.5 Advanced Accelerator Applications Latest Developments

12.13 SIEMENS

12.13.1 SIEMENS Company Information

12.13.2 SIEMENS Radiopharmaceuticals Product Offered

12.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 SIEMENS Main Business Overview

12.13.5 SIEMENS Latest Developments

12.14 Dongcheng

12.14.1 Dongcheng Company Information

12.14.2 Dongcheng Radiopharmaceuticals Product Offered

12.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Dongcheng Main Business Overview

12.14.5 Dongcheng Latest Developments

12.15 Navidea

12.15.1 Navidea Company Information

12.15.2 Navidea Radiopharmaceuticals Product Offered

12.15.3 Navidea Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Navidea Main Business Overview

12.15.5 Navidea Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Radiopharmaceuticals Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Diagnostic Radioisotopes

Table 3. Major Players of Therapeutic Radioisotopes

Table 4. Global Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)

Table 5. Global Radiopharmaceuticals Sales Market Share by Type (2016-2021)

Table 6. Global Radiopharmaceuticals Revenue by Type (2016-2021) & ($ million)

Table 7. Global Radiopharmaceuticals Revenue Market Share by Type (2016-2021)

Table 8. Global Radiopharmaceuticals Sale Price by Type (2016-2021)

Table 9. Global Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)

Table 10. Global Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Table 11. Global Radiopharmaceuticals Value by Application (2016-2021)

Table 12. Global Radiopharmaceuticals Revenue Market Share by Application (2016-2021)

Table 13. Global Radiopharmaceuticals Sale Price by Application (2016-2021)

Table 14. Global Radiopharmaceuticals Sales by Company (2019-2021) & (K Dose)

Table 15. Global Radiopharmaceuticals Sales Market Share by Company (2019-2021)

Table 16. Global Radiopharmaceuticals Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Radiopharmaceuticals Revenue Market Share by Company (2019-2021)

Table 18. Global Radiopharmaceuticals Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Radiopharmaceuticals Producing Area Distribution and Sales Area

Table 20. Players Radiopharmaceuticals Products Offered

Table 21. Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Radiopharmaceuticals Sales by Region (2016-2021) (K Dose)

Table 25. Global Radiopharmaceuticals Sales Market Share by Region (2016-2021)

Table 26. Global Radiopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Radiopharmaceuticals Revenue Market Share by Region (2016-2021)

Table 28. Americas Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)

Table 29. Americas Radiopharmaceuticals Sales Market Share by Country (2016-2021)

Table 30. Americas Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Radiopharmaceuticals Revenue Market Share by Country (2016-2021)

Table 32. Americas Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)

Table 33. Americas Radiopharmaceuticals Sales Market Share by Type (2016-2021)

Table 34. Americas Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)

Table 35. Americas Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Table 36. APAC Radiopharmaceuticals Sales by Region (2016-2021) & (K Dose)

Table 37. APAC Radiopharmaceuticals Sales Market Share by Region (2016-2021)

Table 38. APAC Radiopharmaceuticals Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Radiopharmaceuticals Revenue Market Share by Region (2016-2021)

Table 40. APAC Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)

Table 41. APAC Radiopharmaceuticals Sales Market Share by Type (2016-2021)

Table 42. APAC Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)

Table 43. APAC Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Table 44. Europe Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)

Table 45. Europe Radiopharmaceuticals Sales Market Share by Country (2016-2021)

Table 46. Europe Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Radiopharmaceuticals Revenue Market Share by Country (2016-2021)

Table 48. Europe Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)

Table 49. Europe Radiopharmaceuticals Sales Market Share by Type (2016-2021)

Table 50. Europe Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)

Table 51. Europe Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Radiopharmaceuticals Sales by Country (2016-2021) & (K Dose)

Table 53. Middle East & Africa Radiopharmaceuticals Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Radiopharmaceuticals Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Radiopharmaceuticals Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Radiopharmaceuticals Sales by Type (2016-2021) & (K Dose)

Table 57. Middle East & Africa Radiopharmaceuticals Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Radiopharmaceuticals Sales by Application (2016-2021) & (K Dose)

Table 59. Middle East & Africa Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Radiopharmaceuticals

Table 61. Key Application and Potential Industries of Radiopharmaceuticals

Table 62. Key Challenges of Radiopharmaceuticals

Table 63. Key Trends of Radiopharmaceuticals

Table 64. Radiopharmaceuticals Distributors List

Table 65. Radiopharmaceuticals Customer List

Table 66. Global Radiopharmaceuticals Sales Forecast by Region (2021-2026) & (K Dose)

Table 67. Global Radiopharmaceuticals Consumption Market Forecast by Region

Table 68. Global Radiopharmaceuticals Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Radiopharmaceuticals Sales Forecast by Country (2021-2026) & (K Dose)

Table 71. Americas Radiopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Radiopharmaceuticals Sales Forecast by Region (2021-2026) & (K Dose)

Table 73. APAC Radiopharmaceuticals Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Radiopharmaceuticals Sales Forecast by Country (2021-2026) & (K Dose)

Table 75. Europe Radiopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Radiopharmaceuticals Sales Forecast by Country (2021-2026) & (K Dose)

Table 77. Middle East & Africa Radiopharmaceuticals Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Radiopharmaceuticals Sales Forecast by Type (2021-2026) & (K Dose)

Table 79. Global Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Radiopharmaceuticals Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Radiopharmaceuticals Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Radiopharmaceuticals Sales Forecast by Application (2021-2026) & (K Dose)

Table 83. Global Radiopharmaceuticals Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Radiopharmaceuticals Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Radiopharmaceuticals Revenue Market Share Forecast by Application (2021-2026)

Table 86. Bracco Imaging Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 87. Bracco Imaging Radiopharmaceuticals Product Offered

Table 88. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 89. Bracco Imaging Main Business

Table 90. Bracco Imaging Latest Developments

Table 91. Bayer Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 92. Bayer Radiopharmaceuticals Product Offered

Table 93. Bayer Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 94. Bayer Main Business

Table 95. Bayer Latest Developments

Table 96. Mallinckrodt Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 97. Mallinckrodt Radiopharmaceuticals Product Offered

Table 98. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 99. Mallinckrodt Main Business

Table 100. Mallinckrodt Latest Developments

Table 101. Nordion Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 102. Nordion Radiopharmaceuticals Product Offered

Table 103. Nordion Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 104. Nordion Main Business

Table 105. Nordion Latest Developments

Table 106. Triad Isotopes Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 107. Triad Isotopes Radiopharmaceuticals Product Offered

Table 108. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 109. Triad Isotopes Main Business

Table 110. Triad Isotopes Latest Developments

Table 111. Lantheus Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 112. Lantheus Radiopharmaceuticals Product Offered

Table 113. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 114. Lantheus Main Business

Table 115. Lantheus Latest Developments

Table 116. IBA Group Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 117. IBA Group Radiopharmaceuticals Product Offered

Table 118. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 119. IBA Group Main Business

Table 120. IBA Group Latest Developments

Table 121. GE Healthcare Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 122. GE Healthcare Radiopharmaceuticals Product Offered

Table 123. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 124. GE Healthcare Main Business

Table 125. GE Healthcare Latest Developments

Table 126. China Isotope & Radiation Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 127. China Isotope & Radiation Radiopharmaceuticals Product Offered

Table 128. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 129. China Isotope & Radiation Main Business

Table 130. China Isotope & Radiation Latest Developments

Table 131. Jubilant Pharma Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 132. Jubilant Pharma Radiopharmaceuticals Product Offered

Table 133. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 134. Jubilant Pharma Main Business

Table 135. Jubilant Pharma Latest Developments

Table 136. Eli Lilly Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 137. Eli Lilly Radiopharmaceuticals Product Offered

Table 138. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 139. Eli Lilly Main Business

Table 140. Eli Lilly Latest Developments

Table 141. Advanced Accelerator Applications Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 142. Advanced Accelerator Applications Radiopharmaceuticals Product Offered

Table 143. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 144. Advanced Accelerator Applications Main Business

Table 145. Advanced Accelerator Applications Latest Developments

Table 146. SIEMENS Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 147. SIEMENS Radiopharmaceuticals Product Offered

Table 148. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 149. SIEMENS Main Business

Table 150. SIEMENS Latest Developments

Table 151. Dongcheng Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 152. Dongcheng Radiopharmaceuticals Product Offered

Table 153. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 154. Dongcheng Main Business

Table 155. Dongcheng Latest Developments

Table 156. Navidea Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors

Table 157. Navidea Radiopharmaceuticals Product Offered

Table 158. Navidea Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 159. Navidea Main Business

Table 160. Navidea Latest Developments

List of Figures

Figure 1. Picture of Radiopharmaceuticals

Figure 2. Radiopharmaceuticals Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Radiopharmaceuticals Sales Growth Rate 2016-2026 (K Dose)

Figure 7. Global Radiopharmaceuticals Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Radiopharmaceuticals Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Diagnostic Radioisotopes

Figure 10. Product Picture of Therapeutic Radioisotopes

Figure 11. Global Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 12. Global Radiopharmaceuticals Revenue Market Share by Type (2016-2021)

Figure 13. Radiopharmaceuticals Consumed in Oncology

Figure 14. Global Radiopharmaceuticals Market: Oncology (2016-2021) & (K Dose)

Figure 15. Radiopharmaceuticals Consumed in Cardiology

Figure 16. Global Radiopharmaceuticals Market: Cardiology (2016-2021) & (K Dose)

Figure 17. Radiopharmaceuticals Consumed in Other

Figure 18. Global Radiopharmaceuticals Market: Other (2016-2021) & (K Dose)

Figure 19. Global Radiopharmaceuticals Sales Market Share by Application (2016-2021)

Figure 20. Global Radiopharmaceuticals Revenue Market Share by Application in 2020

Figure 21. Radiopharmaceuticals Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Radiopharmaceuticals Revenue Market Share by Company in 2020

Figure 23. Global Radiopharmaceuticals Sales Market Share by Regions (2016-2021)

Figure 24. Global Radiopharmaceuticals Revenue Market Share by Region in 2020

Figure 25. Americas Radiopharmaceuticals Sales 2016-2021 (K Dose)

Figure 26. Americas Radiopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 27. APAC Radiopharmaceuticals Sales 2016-2021 (K Dose)

Figure 28. APAC Radiopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 29. Europe Radiopharmaceuticals Sales 2016-2021 (K Dose)

Figure 30. Europe Radiopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Radiopharmaceuticals Sales 2016-2021 (K Dose)

Figure 32. Middle East & Africa Radiopharmaceuticals Revenue 2016-2021 ($ Millions)

Figure 33. Americas Radiopharmaceuticals Sales Market Share by Country in 2020

Figure 34. Americas Radiopharmaceuticals Revenue Market Share by Country in 2020

Figure 35. Americas Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 36. Americas Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 37. United States Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Radiopharmaceuticals Sales Market Share by Region in 2020

Figure 42. APAC Radiopharmaceuticals Revenue Market Share by Regions in 2020

Figure 43. APAC Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 44. APAC Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 45. China Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Radiopharmaceuticals Sales Market Share by Country in 2020

Figure 52. Europe Radiopharmaceuticals Revenue Market Share by Country in 2020

Figure 53. Europe Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 54. Europe Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 55. Germany Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Radiopharmaceuticals Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Radiopharmaceuticals Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 64. Egypt Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Radiopharmaceuticals Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

Sample Request is not available